INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,623 Cr | ₹1,394 Cr | ₹1,133 Cr | ₹1,794 Cr | ₹1,749 Cr |
What is the latest Total Liabilities ratio of INDSWIFT LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹1,623 Cr |
| Mar2025 | ₹1,394 Cr |
| Mar2024 | ₹1,133 Cr |
| Mar2023 | ₹1,794 Cr |
| Mar2022 | ₹1,749 Cr |
How is Total Liabilities of INDSWIFT LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,623 Cr | 16.45 | |
| Mar2025 | ₹1,394 Cr | 22.98 | |
| Mar2024 | ₹1,133 Cr | -36.84 | |
| Mar2023 | ₹1,794 Cr | 2.59 | |
| Mar2022 | ₹1,749 Cr | - | |
Compare Total Liabilities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹2,919.0 Cr | -8.6% | -3.5% | 223.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | -8.6% |
-3.5% |
223.3% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses